Skip to content

Local Thrombolytics Before Thrombectomy in STEMI

Local Delivery of thrombolytIcs Before Thrombectomy in patientS With ST-elevatiOn myocardiaL Infarction Undergoing Primary percuTaneous Coronary interventION - The DISSOLUTION Randomized Trial

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01568931
Acronym
DISSOLUTION
Enrollment
100
Registered
2012-04-02
Start date
2014-01-31
Completion date
2021-03-31
Last updated
2020-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

thrombectomy

Brief summary

Background Prompt reperfusion with percutaneous coronary intervention (PCI) in the setting of ST-elevation myocardial infarction (STEMI) improves clinical outcomes through salvage of myocardial tissue. Although the use of thrombus aspiration with PCI can result in improved rates of normal epicardial flow and myocardial perfusion, several unmet needs remain. Purpose The purpose of this trial will be to evaluate the hypothesis that local delivery of thrombolytics vs. saline infusion prior to thrombus aspiration and PCI is safe and effective in patients with STEMI.

Detailed description

The study will select patients with ST-elevation myocardial infarction (STEMI) with angiographic evidence of massive thrombosis in the culprit artery undergoing manual thrombectomy followed by primary percutaneous coronary intervention (PCI). Patients will be randomized to receive local bolus of 200,000 units urokinase or saline solution

Interventions

intracoronary, urokinase, 200,000 Units, bolus

DRUGSaline

intracoronary, saline, bolus 1 cc

Sponsors

University of Roma La Sapienza
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ST-elevation myocardial infarction * angiographic evidence of massive thrombosis in the culprit artery * Indication to manual thrombectomy followed by primary percutaneous coronary intervention (PCI) * Able to understand and willing to sign the informed CF

Exclusion criteria

* Women of child bearing potential patients must demonstrate a negative pregnancy test performed within 24 hours before CT

Design outcomes

Primary

MeasureTime frameDescription
Outcomes at 30 daysUp to 30 days30-day occurrence of death, new Q-wave myocardial infarction, coronary artery bypass grafting, target lesion revascularization, stroke, or stent thrombosis

Secondary

MeasureTime frameDescription
Myocardial reperfusion after Primary CIUp to 90 minutes after Primary PCIST-segment resolution (STR)\>70% as assessed 90 minutes after Primary PCI
Left ventricular remodelingUp to 1 year after Primary PCIA change in left ventricular end-diastolic volume\>20% (compared with baseline values) as assessed at 1-year echocardiography
5-year MACEUp to 5 years after Primary PCIDeath, reinfarction, new-onset severe heart failure, and rehospitalization for heart failure

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026